Posts

Showing posts with the label Urinary Bag Market

Urinary Bag Market Segment Overview, Regional Analysis and Forecast to 2031

Image
The global urinary bag market will rise at a CAGR of 4.4% CAGR between 2021 and 2031. Between 2016 and 2020, the global urinary bag market grew at a moderate CAGR of more than 3.5%. According to a World Health Organization (WHO) report, the prevalence of urine incontinence in population-based studies ranged from 9.9% to 36.1% (2-4), with older women being twice as likely as older men. Urinary bags are frequently employed in the treatment of urine incontinence, ulcerative colitis, retention, and spinal cord injury. According to the Continence Foundation of Australia, around 38% of women and 13% of men in Australia were affected by urinary incontinence in 2019, accounting for more than one in every three Australians. According to the survey, the illness is more common in women (61%), persons with arthritis (57%), diabetes (46%), impairments (47%), mental health disorders (53%), and males with prostate problems (54%). The United States controls more than 90% of the North American market....

Urinary Bag Market Segment Overview, Regional Analysis and Forecast to 2031

Image
The global urinary bag market will rise at a CAGR of 4.4% CAGR between 2021 and 2031. Between 2016 and 2020, the global urinary bag market grew at a moderate CAGR of more than 3.5%. According to a World Health Organization (WHO) report, the prevalence of urine incontinence in population-based studies ranged from 9.9% to 36.1% (2-4), with older women being twice as likely as older men. Urinary bags are frequently employed in the treatment of urine incontinence, ulcerative colitis, retention, and spinal cord injury. According to the Continence Foundation of Australia, around 38% of women and 13% of men in Australia were affected by urinary incontinence in 2019, accounting for more than one in every three Australians. According to the survey, the illness is more common in women (61%), persons with arthritis (57%), diabetes (46%), impairments (47%), mental health disorders (53%), and males with prostate problems (54%). The United States controls more than 90% of the North American market....